DrugPatentWatch Database Preview
Email this page to a colleague» See Plans and Pricing
« Back to Dashboard
Vectical is a drug marketed by Galderma Labs Lp and is included in one NDA.
The generic ingredient in VECTICAL is calcitriol. There are ten drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the calcitriol profile page.
A generic version of VECTICAL was approved as calcitriol by TEVA on October 12th, 2001.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Galderma Labs Lp||VECTICAL||calcitriol||OINTMENT;TOPICAL||022087-001||Jan 23, 2009||RX||Yes||Yes||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|